STOCK TITAN

Henry Schein Medical Expands SolutionsHub with Colaborate

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Very Positive)
Tags

Henry Schein Medical (NASDAQ:HSIC) has expanded its SolutionsHub by partnering with Colaborate, a management consulting firm specializing in medical laboratory services. The collaboration aims to enhance clinical laboratory operations across the United States by combining Colaborate's consulting expertise with Henry Schein's extensive network and capabilities.

Colaborate, established in 2005, has served over 500 institutions with services including billing, compliance assessments, consolidation assessments, and performance enhancements. The partnership will help laboratories address financial pressures and regulatory demands while improving operational efficiency and financial sustainability.

Henry Schein Medical (NASDAQ:HSIC) ha ampliato il suo SolutionsHub stringendo una partnership con Colaborate, una società di consulenza manageriale specializzata nei servizi di laboratorio medico. La collaborazione punta a migliorare le attività dei laboratori clinici negli Stati Uniti, combinando l’esperienza consulenziale di Colaborate con l’ampia rete e le capacità di Henry Schein.

Fondata nel 2005, Colaborate ha assistito oltre 500 istituzioni offrendo servizi quali fatturazione, valutazioni di conformità, analisi per consolidamenti e miglioramento delle prestazioni. La partnership aiuterà i laboratori a fronteggiare pressioni finanziarie e requisiti normativi, migliorando al contempo efficienza operativa e sostenibilità economica.

Henry Schein Medical (NASDAQ:HSIC) ha ampliado su SolutionsHub al asociarse con Colaborate, una consultora de gestión especializada en servicios de laboratorio médico. La colaboración busca optimizar las operaciones de laboratorios clínicos en Estados Unidos, combinando la experiencia consultora de Colaborate con la amplia red y capacidades de Henry Schein.

Fundada en 2005, Colaborate ha atendido a más de 500 instituciones, ofreciendo servicios como facturación, evaluaciones de cumplimiento, estudios de consolidación y mejoras de rendimiento. La asociación ayudará a los laboratorios a afrontar presiones financieras y exigencias regulatorias, mejorando la eficiencia operativa y la viabilidad financiera.

Henry Schein Medical (NASDAQ:HSIC)는 의료 실험실 서비스 전문 경영 컨설팅 회사인 Colaborate와 협력하여 SolutionsHub를 확장했습니다. 이번 협력은 Colaborate의 컨설팅 전문성과 Henry Schein의 광범위한 네트워크 및 역량을 결합해 미국 전역의 임상 실험실 운영을 향상시키는 것을 목표로 합니다.

2005년 설립된 Colaborate는 청구, 규정 준수 평가, 통합 검토 및 성과 개선 등 서비스를 통해 500개 이상의 기관을 지원해 왔습니다. 이 파트너십은 실험실이 재정적 압박과 규제 요구 사항에 대응하는 동시에 운영 효율성과 재정적 지속 가능성을 개선하도록 도울 것입니다.

Henry Schein Medical (NASDAQ:HSIC) a étendu son SolutionsHub en s’associant à Colaborate, un cabinet de conseil en gestion spécialisé dans les services de laboratoires médicaux. Cette collaboration vise à améliorer les opérations des laboratoires cliniques aux États-Unis en combinant l’expertise de conseil de Colaborate avec le vaste réseau et les capacités de Henry Schein.

Fondée en 2005, Colaborate a accompagné plus de 500 institutions, en fournissant des services tels que la facturation, les évaluations de conformité, les études de consolidation et l’amélioration des performances. Le partenariat aidera les laboratoires à faire face aux contraintes financières et aux exigences réglementaires, tout en améliorant l’efficacité opérationnelle et la viabilité financière.

Henry Schein Medical (NASDAQ:HSIC) hat sein SolutionsHub erweitert und eine Partnerschaft mit Colaborate geschlossen, einer Managementberatungsfirma, die auf medizinische Labordienstleistungen spezialisiert ist. Ziel der Zusammenarbeit ist es, die Abläufe in klinischen Laboren in den Vereinigten Staaten zu verbessern, indem Colaborates Beratungskompetenz mit Henry Scheins großem Netzwerk und Leistungsangebot kombiniert wird.

Colaborate wurde 2005 gegründet und hat über 500 Einrichtungen betreut, mit Leistungen wie Abrechnung, Compliance-Bewertungen, Konsolidierungsanalysen und Leistungssteigerungen. Die Partnerschaft soll Laboren helfen, finanziellen Druck und regulatorische Anforderungen zu bewältigen und zugleich die operative Effizienz und finanzielle Nachhaltigkeit zu erhöhen.

Positive
  • Strategic expansion into laboratory management consulting services
  • Access to Colaborate's established client base of 500+ institutions
  • Enhanced service offering for clinical laboratories addressing compliance and efficiency needs
  • Strengthened position in the growing laboratory services market
Negative
  • None.

Insights

Henry Schein's SolutionsHub expansion with Colaborate strengthens its laboratory services portfolio, potentially increasing revenue streams and market position.

Henry Schein Medical's integration of Colaborate into its SolutionsHub represents a strategic expansion of its laboratory services ecosystem. This partnership combines Henry Schein's extensive distribution network with Colaborate's 20-year consulting expertise serving over 500 institutions since 2005.

The timing is particularly relevant as clinical laboratories face intensifying financial and regulatory pressures. By adding specialized laboratory management consulting capabilities, Henry Schein addresses critical pain points for laboratory operators: compliance management, operational efficiency, and financial sustainability.

Colaborate brings valuable service offerings including billing and collections assistance, compliance assessments, consolidation guidance, contract reviews, and equipment acquisition support. These high-margin consulting services complement Henry Schein's existing product portfolio of laboratory equipment and diagnostics.

This expansion aligns with healthcare industry trends toward integrated solution offerings rather than standalone products. For Henry Schein, it represents an opportunity to deepen customer relationships, potentially increasing customer retention and lifetime value while creating new revenue streams beyond traditional product sales.

The partnership positions Henry Schein to capture more value from the laboratory market by moving upstream into professional services, allowing it to participate in the operational success of its customers rather than merely supplying their equipment needs. This "solutions approach" could strengthen Henry Schein's competitive positioning against both traditional competitors and new market entrants.

Full-Service Laboratory Management Firm Helps Elevate Clinical Lab Operations

NEW YORK, Sept. 9, 2025 /PRNewswire/ -- Henry Schein Medical, the U.S. medical business of Henry Schein, Inc., has expanded its SolutionsHub™ with the addition of Colaborate, a full-service management consulting firm dedicated to serving independent and hospital-based medical laboratories. Together, Henry Schein and Colaborate will empower clinical laboratories across the U.S. to maintain compliance, enhance operational efficiency, and increase financial sustainability.

Through this expansion, laboratories will have direct access to Colaborate's consulting expertise, combined with the reliability and reach of Henry Schein's network and lab capabilities. The Colaborate team is comprised of experienced business, technical, and advisory consultation professionals. Since 2005, Colaborate has served the needs of more than 500 institutions with billing and collections, compliance assessments, consolidation and merger assessments, contract reviews, equipment acquisitions, benchmarking, performance enhancements, and more.

"Clinical laboratories today face increasing financial pressures and regulatory demand, which can oftentimes be a struggle to balance," said Emily Jimenez, Director of Solution Sales at Henry Schein Medical. "By adding Colaborate to our SolutionsHub, we are continuing our mission to help our customers improve patient outcomes, increase profitability, and run a more efficient business."

Henry Schein and Colaborate are uniquely positioned to provide laboratories with resources and expertise to foster success for labs across the health care landscape.

"Joining forces with Henry Schein is an incredible milestone," said Kevin Hunter, Founder & CEO at Colaborate. "We're excited to bring our deep industry expertise to Henry Schein's vast network of customers. Our mission is clear: simplify laboratory builds and ongoing management, streamline regulatory compliance, and optimize financial outcomes – allowing health care organizations to focus on their core mission of exceptional patient care."

Henry Schein Medical supports laboratories by providing a wide range of products, services, and technology solutions tailored to their needs. This includes laboratory equipment, rapid diagnostics, and more.

"We are dedicated to serving laboratories with not only products, but also solutions that help our customers enhance financial and operational performance," said Gary Dennis, Senior Director of Laboratory Services at Henry Schein Medical. "Our relationship with Colaborate significantly advances our existing capabilities, helping our laboratory customers manage profitable laboratories while furthering optimal health outcomes."

To learn more about Colaborate or to explore Henry Schein Medical's full portfolio of solutions, please click here.

About Henry Schein, Inc.

Henry Schein, Inc. (Nasdaq: HSIC) is a solutions company for health care professionals powered by a network of people and technology. With more than 25,000 Team Schein Members worldwide, the Company's network of trusted advisors provides more than 1 million customers globally with more than 300 valued solutions that help improve operational success and clinical outcomes. Our Business, Clinical, Technology, and Supply Chain solutions help office-based dental and medical practitioners work more efficiently so they can provide quality care more effectively. These solutions also support dental laboratories, government and institutional health care clinics, as well as other alternate care sites.

Henry Schein operates through a centralized and automated distribution network, with a selection of more than 300,000 branded products and Henry Schein corporate brand products in our distribution centers.

A FORTUNE 500 Company and a member of the S&P 500® index, Henry Schein is headquartered in Melville, N.Y., and has operations or affiliates in 33 countries and territories. The Company's sales reached $12.7 billion in 2024 and have grown at a compound annual rate of approximately 11.2 percent since Henry Schein became a public company in 1995.

For more information, visit Henry Schein at

www.henryschein.com, Facebook.com/HenrySchein, Instagram.com/HenrySchein, LinkedIn.com/Company/HenrySchein, and @HenrySchein on X.

Media Contacts:

Adam Hunter
Director, Colaborate
ahunter@colaborate.com

Lauren DelGuidice
Associate Manager, Corporate Media Relations, Henry Schein, Inc.
Lauren.Delguidice@henryschein.com
631.479.7309

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/henry-schein-medical-expands-solutionshub-with-colaborate-302548418.html

SOURCE Colaborate

FAQ

What is the significance of Henry Schein's partnership with Colaborate for HSIC stock?

The partnership expands Henry Schein Medical's SolutionsHub, strengthening its position in laboratory services by adding Colaborate's consulting expertise and access to 500+ institutions, potentially driving new revenue streams.

What services will Colaborate bring to Henry Schein Medical's portfolio?

Colaborate provides billing and collections, compliance assessments, consolidation and merger assessments, contract reviews, equipment acquisitions, benchmarking, and performance enhancements for medical laboratories.

How many institutions has Colaborate served since its founding?

Since its establishment in 2005, Colaborate has served more than 500 institutions with its laboratory management consulting services.

What is Henry Schein Medical's SolutionsHub?

SolutionsHub is Henry Schein Medical's portfolio of solutions that provides laboratory equipment, rapid diagnostics, and services designed to help customers improve patient outcomes, increase profitability, and enhance operational efficiency.

Who are the key executives involved in the Henry Schein-Colaborate partnership?

Key executives include Emily Jimenez (Director of Solution Sales at Henry Schein Medical), Kevin Hunter (Founder & CEO at Colaborate), and Gary Dennis (Senior Director of Laboratory Services at Henry Schein Medical).
Henry Schein

NASDAQ:HSIC

HSIC Rankings

HSIC Latest News

HSIC Latest SEC Filings

HSIC Stock Data

8.42B
102.46M
0.87%
114.58%
6.42%
Medical Distribution
Wholesale-medical, Dental & Hospital Equipment & Supplies
Link
United States
MELVILLE